Boan Completes China Phase 3 Trial of BA1104, Meets Primary EndpointTip Ranks·Nov 17, 2026 at 04:39 AM069550.00%
Shandong Boan Wins China Approval to Begin BA2201 Clinical TrialsPUBT·Nov 6, 2026 at 04:07 AM069550.00%
Smoore International Discloses Share Buyback in HKEX Next-Day ReturnPUBT·Nov 2, 2026 at 11:33 AM069550.00%
Smoore International Files HKEX Next Day Disclosure Return Announcing Share BuybackPUBT·Oct 21, 2026 at 01:05 PM06969-0.26%
China Merchants Port Sells a Stake, and Five Other Hong Kong Moves You MissedGlobal Report·Oct 22, 2026 at 10:48 AM00144-0.34%02729-1.37%
Why Hong Kong's Small Caps Are Priced by Deals, Not ProductsGlobal Report·Oct 13, 2026 at 10:50 AM00975-3.35%02507-1.01%
Strategic Pivots Define Hong Kong Small-Cap Resurgence Amid Sector DivergenceGlobal Report·Oct 13, 2026 at 09:24 AM02883+0.44%00875+9.38%
Weekly Recap | BOAN BIOTECH -7.19%, consensus target above spotWeekly Review·Oct 10, 2026 at 05:45 AM069550.00%
Boan Biotech Taps Luye Subsidiary to Promote Key Biosimilar DrugsTip Ranks·Oct 9, 2026 at 02:07 PM069550.00%
Shimao Leads Property Rally as Two Hong Kong Small Caps Stay SuspendedGlobal Report·Sep 29, 2026 at 10:51 AM01308+1.31%01951+0.67%
Weekly Recap | BOAN BIOTECH +9.7%, rally then pullbackWeekly Review·Sep 26, 2026 at 05:41 AM069550.00%
Inside the HK Market Shuffle: Infrastructure Moves, Biotech Approvals, and Consumer PivotsGlobal Report·Sep 22, 2026 at 11:32 AM026210.00%00119+1.00%